Search - tctmd.com

Displaying 121 - 140 of 243

Sort: Relevancy | Date

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

September 24, 2018

Novel LAA Closure Device Shows Promise in Early Experience

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

September 22, 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

September 17, 2018

Edoxaban Looks Good for Asians With A-fib in Real-world Analysis

News Daily News

Edoxaban Looks Good for Asians With A-fib in Real-world Analysis

August 14, 2018

Experts Give Strong Support for PFO Closure in New ‘Rapid Recommendations’

News Daily News

Experts Give Strong Support for PFO Closure in New ‘Rapid Recommendations’

July 26, 2018

NOACs Particularly Beneficial for Women With A-fib, Study Suggests

News Daily News

NOACs Particularly Beneficial for Women With A-fib, Study Suggests

July 11, 2018

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

May 16, 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

May 14, 2018

Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis

News Conference News ACC 2018

Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis

March 12, 2018

Weighing of Female Sex in Stroke Risk Scores Needs Rethink in A-fib

News Daily News

Weighing of Female Sex in Stroke Risk Scores Needs Rethink in A-fib

February 26, 2018

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

News Daily News

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

January 23, 2018

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

News Daily News

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

January 11, 2018

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

November 22, 2017

RE-DUAL PCI Findings Consistent Across Key Subgroups

News Conference News AHA 2017

RE-DUAL PCI Findings Consistent Across Key Subgroups

November 16, 2017

Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma

News Conference News AHA 2017

Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma

November 15, 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

November 02, 2017

Live From Denver: TCT 2017, Day Four

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

November 02, 2017

Adjunctive Pharmacotherapy During and After TAVR: Current Trends, New Studies, and the Case for Short-term (3-6 months) Systemic Anticoagulation

Presentation TCT 2017

Adjunctive Pharmacotherapy During and After TAVR: Current Trends, New Studies, and the Case for Short-term (3-6 months) Systemic Anticoagulation

Presenter: Eberhard Grube, James B. Hermiller Jr., Pascal Vranckx

November 01, 2017

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

September 15, 2017

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

News Conference News ESC 2017

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

September 05, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.